Abstract:OBJECTIVE To analyze the specificity of ESAT-6/CFP-10 fusion protein as an antigen of tuberculosis and explore the clinical application of ESAT-6/CFP-10 enzyme-linked immunospot(ELISPOT) assay in diagnosis of tuberculosis.METHODS ESAT-6/CFP-10-ELISPOT assay was performed for detection of IFN-γ-secreting T cells which were specific for M.tuberculosis antigens.Blood samples were from 65 patients only with tuberculosis,16 patients with co-infection of HIV and TB,32 patients with other respiratory diseases,and 30 healthy individuals.RESULTS As compared with ESAT-6/CFP-10-ELISPOT assay and TST for 81 patients with tuberculosis,the positive rate of ESAT-6/CFP-10-ELISPOT was 98.8%,and the positive rate of TST was 56.8%;the positive rates of ESAT-6/CFP-10-ELISPOT in smear positive tuberculosis group,smear negative tuberculosis group,and co-infection HIV and TB group were 100.0%,97.1% and100.0% respectively,suggesting significantly higher sensitivity than that of sputum smear test,and the differences were not statistically significant.There was one positive case in HIV infection group,both the non-tuberculosis respiratory tract disease group and the control group were negative,which indicated that the specificity of ESAT-6/CFP-10-ELISPOT was 98.8%.CONCLUSION ESAT-6/CFP-10 fusion protein excellently stimulated T cells to secret IFN-γ.It can serveas specific antigen which is suitable for the diagnosis of tuberculosis and be applied for the detection of ELISPOT.ESAT-6/CFP-10-ELISPOT is valuable for the diagnosis of tuberculosis.

Clinical Application and Antigenicity of ESAT-6/CFP-10 Fusion Protein in Diagnosis of Tuberculosis